Literature DB >> 8935378

Tumor-associated hypereosinophilia: report of four cases.

W C Chang1, C C Liaw, P N Wang, Y H Tsai, S Hsueh.   

Abstract

Hypereosinophilia is a rare manifestation of cancer. We reported four cases of tumor-associated hypereosinophilia. These cases presented with peripheral hypereosinophilia and disseminated metastatic malignancies. All cases were male, including two cases with cancer of unknown primary site, one with hepatocellular carcinoma, and one with a liver tumor. The age ranged from 27 to 55 years. They all had liver involvement. Two cases had bone marrow metastases. The leukocyte counts ranged from 78,600/microliters to 190,000/microliters. The percentage of eosinophils ranged from 20% to 77%. The eosinophil counts ranged from 15,720 to 126,350/microliters with a mean of 74,700/microliters. The first three cases died within 8 days after the malignancies were pathologically confirmed. We suggest that peripheral hypereosinophilia is a poor prognostic sign which is frequently associated with disseminated cancer.

Entities:  

Mesh:

Year:  1996        PMID: 8935378

Source DB:  PubMed          Journal:  Changgeng Yi Xue Za Zhi


  3 in total

1.  Impact of chemotherapy on eosinophilia-associated advanced rectal cancer: A case report and review of the literature.

Authors:  Maki Inoue; Jun Kadono; Hiroshi Sugita; Toshihiro Nakazono; Shunsuke Motoi; Iwao Kitazono; Yuko Goto; Yoshihiko Fukukura; Makoto Yoshimitsu; Takaharu Misaka; Yutaka Imoto
Journal:  Oncol Lett       Date:  2016-11-08       Impact factor: 2.967

2.  Severe paraneoplastic hypereosinophilia in metastatic renal cell carcinoma.

Authors:  Tilman Todenhöfer; Stefan Wirths; Claus Hann von Weyhern; Stefan Heckl; Marius Horger; Joerg Hennenlotter; Arnulf Stenzl; Lothar Kanz; Christian Schwentner
Journal:  BMC Urol       Date:  2012-03-21       Impact factor: 2.264

3.  Rapidly evolving asymptomatic eosinophilia in a patient with lung adenocarcinoma causes cognitive disturbance and respiratory insufficiency: Case report.

Authors:  Cheng-Hsiang Lo; Yee-Min Jen; Wen-Chiuan Tsai; Ping-Ying Chung; Woei-Yau Kao
Journal:  Oncol Lett       Date:  2012-11-09       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.